| # | Drug | Count |
|---|---|---|
| 0 | PALBOCICLIB | 876 |
| 1 | FULVESTRANT | 675 |
| 2 | LETROZOLE | 569 |
| 3 | LETROZOLE TABLETS | 420 |
| 4 | NIRAPARIB | 359 |
| 5 | CAPECITABINE | 351 |
| 6 | RIBOCICLIB | 350 |
| 7 | EVEROLIMUS | 267 |
| 8 | EXEMESTANE | 262 |
| 9 | DENOSUMAB | 257 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ELACESTRANT | 230 | 0.0320 |
| 1 | TRASTUZUMAB-QYYP | 11 | 0.0282 |
| 2 | FULVESTRANT | 675 | 0.0201 |
| 3 | NIRAPARIB | 359 | 0.0162 |
| 4 | EXEMESTANE | 262 | 0.0122 |
| 5 | RIBOCICLIB | 350 | 0.0107 |
| 6 | PALBOCICLIB | 876 | 0.0092 |
| 7 | LETROZOLE | 569 | 0.0091 |
| 8 | OLAPARIB | 185 | 0.0086 |
| 9 | LETROZOLE TABLETS | 420 | 0.0086 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 1196 |
| 1 | Aromatase Inhibitor [EPC] | 903 |
| 2 | Estrogen Receptor Antagonist [EPC] | 900 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 416 |
| 4 | mTOR Inhibitor Immunosuppressant [EPC] | 268 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 262 |
| 6 | RANK Ligand Inhibitor [EPC] | 257 |
| 7 | Corticosteroid [EPC] | 185 |
| 8 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 185 |
| 9 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 183 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Estrogen Receptor Antagonist [EPC] | 900 | 0.0222 |
| 1 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 185 | 0.0086 |
| 2 | Aromatase Inhibitor [EPC] | 903 | 0.0079 |
| 3 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 5 | 0.0033 |
| 4 | Kinase Inhibitor [EPC] | 1196 | 0.0021 |
| 5 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 143 | 0.0019 |
| 7 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 11 | 0.0017 |
| 8 | Non-Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |
| 9 | Standardized Pollen Allergenic Extract [EPC] | 1 | 0.0016 |